Vanguard Capital Management’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
BCM
Vanguard Capital Management's IMA Position: Q3 2026 in Review
Vanguard Capital Management increased its ImageneBio (IMA) stake by 0.46% in Q3 2026, buying an estimated $8.02K and bringing the position to 321,994 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3460.
Vanguard Capital Management first reported a position in IMA in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.89M in Q2 2026. 37 funds tracked by Wall St. Rank hold IMA as of Q3 2026.
- Vanguard Capital Management held 321,994 shares of ImageneBio worth $1.47M as of Q3 2026.
- Vanguard Capital Management bought 1,476 ImageneBio shares in Q3 2026, an estimated $8.02K.
- ImageneBio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3460 holding.
- Vanguard Capital Management first reported a position in ImageneBio in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's ImageneBio position peaked at $1.89M in Q2 2026.
- 37 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.